Jing Zhan
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Modified thoracoplasty for esophago-pleural fistula following Boerhaave syndrome: a case report.
Journal: Journal of surgical case reports
Published: July 19, 2025
The pharmacokinetics of capmatinib and its efficacy in non-small cell lung cancer treatment: a narrative review.
Journal: Translational lung cancer research
Published: June 17, 2025
Surgical management of 32 primary giant mediastinal neoplasms: a retrospective single-center analysis.
Journal: Journal of cardiothoracic surgery
Published: May 16, 2025
Video-assisted thoracoscopic surgery for adult benign idiopathic bronchoesophageal fistula: a report of two cases.
Journal: Interdisciplinary cardiovascular and thoracic surgery
Published: January 27, 2025
Intratumoral microbiome impacts immune infiltrates in tumor microenvironment and predicts prognosis in esophageal squamous cell carcinoma patients.
Journal: Frontiers in cellular and infection microbiology
Published: February 14, 2023
Novel vandetanib derivative inhibited proliferation and promoted apoptosis of cancer cells under normoxia and hypoxia.
Journal: European journal of pharmacology
Published: December 01, 2021
Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first-line treatment for advanced EGFR-mutant non-small cell lung cancer.
Journal: Clinical and translational medicine
Published: June 09, 2020
A phase Ι study to evaluate the application of photocyanine using pharmacokinetic and pharmacodynamic analysis in patients with malignancy.
Journal: Cancer chemotherapy and pharmacology
Published: October 18, 2019
Determination of Puquitinib in Human Plasma by HPLC-ESI MS/MS: Application to Pharmacokinetic Study.
Determination of Puquitinib in Human Plasma by HPLC-ESI MS/MS: Application to Pharmacokinetic Study.
Journal: European journal of drug metabolism and pharmacokinetics
Published: March 10, 2018
Puquitinib mesylate, an inhibitor of phosphatidylinositol 3-kinase p110δ, for treating relapsed or refractory non-Hodgkin's lymphoma.
Journal: Oncotarget
Published: July 20, 2015
Last Updated: 09/26/2026